These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7026327)
21. The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects. Prince RL; Larkins RG; Alford FP Metabolism; 1981 Mar; 30(3):293-8. PubMed ID: 7010074 [No Abstract] [Full Text] [Related]
22. The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia. Vague P; Moulin JP Metabolism; 1982 Feb; 31(2):139-42. PubMed ID: 7043166 [TBL] [Abstract][Full Text] [Related]
23. Insulin secretory reserve in insulin dependent patients at time of diagnosis and the first 180 days of insulin treatment. Madsbad S; Krarup T; Regeur L; Faber OK; Binder C Acta Endocrinol (Copenh); 1980 Nov; 95(3):359-63. PubMed ID: 7001832 [TBL] [Abstract][Full Text] [Related]
24. Importance of insulin absorption, subcutaneous blood flow, and residual beta-cell function in insulin therapy. Lauritzen T; Binder C; Faber OK Acta Paediatr Scand Suppl; 1980; 283():81-5. PubMed ID: 7010905 [TBL] [Abstract][Full Text] [Related]
26. The relationship between residual insulin secretion and metabolic stability in type 1 (insulin dependent) diabetes. Lutterman JA; Benraad TJ; van 't Laar A Diabetologia; 1981 Aug; 21(2):99-102. PubMed ID: 7021291 [TBL] [Abstract][Full Text] [Related]
27. Beta-cell function and metabolic control in insulin treated diabetics. Madsbad S; McNair P; Faber OK; Binder C; Christiansen C; Transbøl I Acta Endocrinol (Copenh); 1980 Feb; 93(2):196-200. PubMed ID: 6990673 [TBL] [Abstract][Full Text] [Related]
28. B-cell function and blood glucose control in insulin dependent diabetics within the first month of insulin treatment. Faber OK; Binder C Diabetologia; 1977 May; 13(3):263-8. PubMed ID: 873093 [TBL] [Abstract][Full Text] [Related]
29. Lack of effect of improved glycemic control on C-peptide secretion in patients without residual B-cell function. Seigler DE; Reeves ML; Skyler JS Diabetes Care; 1982; 5(3):334-6. PubMed ID: 6756843 [TBL] [Abstract][Full Text] [Related]
30. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus. Clark HE; Matthews DR Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981 [TBL] [Abstract][Full Text] [Related]
31. Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Madsbad S; Krarup T; McNair P; Christiansen C; Faber OK; Transbøl I; Binder C Acta Med Scand; 1981; 210(3):153-6. PubMed ID: 7027749 [TBL] [Abstract][Full Text] [Related]
32. Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes. Glaser B; Leibovich G; Nesher R; Hartling S; Binder C; Cerasi E Acta Endocrinol (Copenh); 1988 Jul; 118(3):365-73. PubMed ID: 3293339 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes. Madsbad S; Faber OK; Binder C; McNair P; Christiansen C; Transbøl I Diabetes; 1978; 27 Suppl 1():262-4. PubMed ID: 344117 [TBL] [Abstract][Full Text] [Related]
34. Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal. Marchesini G; Melli A; Checchia GA; Mattioli L; Capelli M; Cassarani S; Zoli M; Pisi E Metabolism; 1985 Aug; 34(8):695-701. PubMed ID: 3894876 [TBL] [Abstract][Full Text] [Related]
35. The effect of acute hyperglycemia on the plasma C-peptide response to intravenous glucagon or to a mixed meal in insulin-dependent diabetes mellitus. Gjessing HJ; Reinholdt B; Faber OK; Pedersen O Acta Endocrinol (Copenh); 1991 May; 124(5):556-62. PubMed ID: 2028714 [TBL] [Abstract][Full Text] [Related]
36. Residual B cell function in patients with long-standing NIDDM and its relation to metabolic control and diabetic complications. Iwase M; Kikuchi M; Nunoi K; Maki Y; Wakisaka M; Wada M; Fujishima M Endocrinol Jpn; 1988 Dec; 35(6):803-8. PubMed ID: 3074917 [TBL] [Abstract][Full Text] [Related]
37. C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide. Mirel RD; Ginsberg-Fellner F; Horwitz DL; Rayfield EJ Diabetologia; 1980 Sep; 19(3):183-8. PubMed ID: 6997119 [TBL] [Abstract][Full Text] [Related]
38. Duration of residual B-cell function in maturity-onset diabetes. Cignarelli M; Cospite MR; Stefanelli G; Guastamacchia E; Nardelli G; Giorgino R Acta Diabetol Lat; 1984; 21(2):161-6. PubMed ID: 6382892 [TBL] [Abstract][Full Text] [Related]
39. C-peptide response to glucagon in young diabetics. Juang JH; Huang BY; Huang HS; Lin JD; Huang MJ Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):579-83. PubMed ID: 2677232 [TBL] [Abstract][Full Text] [Related]
40. Dynamic study of the blood viscosity of insulin-dependent diabetics by means of an artificial pancreas. Drouin P; Rousselle D; Pointel JP; Voisin G; Stoltz JF; Clemens AH; Debry G Horm Metab Res Suppl; 1979; (8):107-10. PubMed ID: 395064 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]